Health Archive » January, 2020

Health - January, 2020

389 articles

• Legal Risks May Lurk In Employers' Coronavirus Response
• Dental Supplier Resends Arbitration Row To High Court
• Hemp Heavyweights Urge USDA To Ease Testing Rules
• $4.4M Deal Wraps Up Caremark Suit On HIV Status Disclosure
• Why National Injunctions Will Survive High Court Scrutiny
• Blame Deficit On Disastrous Tax Law, Not Social Safety Net
• Meet The Attorneys Taking On Juul In The MDL
• AseraCare FCA Ruling Is A Boon For Health Providers
• Most Lawyers Do Not Understand How AI Works
• 3 Health Care Cos. Begin Trading After IPOs Totaling $420M
• 4 Considerations When Moving To A New Law Firm
• DHS' Wealth Test For Immigrants Will Take Effect Feb. 24
• Ex-Arent Fox Atty Accuses Firm Of Disability Discrimination
• Fugitive Doc Hit With $1.8M Verdict Over Unneeded Surgeries
• American Airlines Pilots Want China Flights Halted Over Virus
• Trump Admin. Sued Over 'Onerous' Regs On Abortion Billing
• States Demand More Gov't Docs In 'Public Charge' Challenge
• Aveanna Healthcare Drops $1.25B Rival Buy Amid FTC Probe
• LabCorp Preserves Win In Blood-Testing Contract Row
• LabMD Racketeering Suit Against Tiversa, Law Firms Axed
• Broad Defense Policy Restrictions Put Higher Ed At Legal Risk
• Altria Wipes Another $4.1B From Value Of Juul Stake
• 'Public Charge' Rule Will Create New Hurdles For Work Visas
• J&J Owes $344M For False Mesh Marketing, Calif. Judge Says
• Fresh EU Cybersecurity Issues For Medical Device Cos.
• A Modest Plan To Streamline Civil Cases In LA Superior Court
• Health Care Group Of The Year: Zuckerman Spaeder
• Opioid MDL's Pharmacy Bellwether Trial Nudged To November
• Tivity Investors Win Class Cert. In Tenn. Stock-Drop Suit
• In Close Vote, 5th Circ. Rejects Rehearing Panel's ACA Punt
• FTC Shakes Up Health Care Mergers Division
• Ex-Prosecutors Unveil Health Care-Focused Firm In NY
• Walgreens Faces Claims It Kept $35M From 'Pharma Bro' Co.
• FDA's Asbestos-In-Talc Finding Doesn't Upend J&J Trial Win
• GAO Says DHA's Talks With $25M Deal Bidders Were Fair
• J&J, Retailers Hit With Prop 65 Suit Over Talc
• Cremation Is Not Spoliation, Md. Court Says In Med Mal Case
• DC Judge Says Gov't Has Dirty Hands In Tribal Land Fight
• GAO Affirms Broad Scope Of $10B VA Health Record Deal
• Real Estate Rumors: Welsh, BentallGreenOak, Aspen Dental
• Pharma CEO Asks Judge To Toss Opioid Trafficking Charge
• Texas Justices Told $3.4M Injury Award Needs Recalculation
• What Courts Are Saying About Litigation Finance Disclosure
• Medical Marijuana Patient Sues Hospital Over Failed Drug Test
• State AGs Diss Pfizer's Effort To Flee Price-Fixing MDL
• New Birth Tourism Visa Rule Is Pregnant With Problems
• Cannabis Grower Wants To Toss Tech Developer's Wage Suit
• Aetna Clients Fight Bid To Nix ERISA Cancer Treatment Suit
• Health Care Group Of The Year: Williams & Connolly
• Novartis, Armed With New IP, Again Sues Over $3B MS Drug
• Insys Founder Says 'Drug Dealer' Accusation Biased Jury
• Quit Saying Purell Prevents Ebola, FDA Tells Sanitizer Co.
• GAO Tells Booz Allen Best Value More Just Than Price, Rating
• Feds Hit With $15M Verdict In Newborn Brain Damage Suit
• Pa. Justices To Weigh Release Of Cannabis License Info
• Public Charge Order Sparks Confusion For Immigration Attys
• Mass. Bill Would Give State More Control Over Pot Business
• Workers See OT Claims Against Pa. State Contractor Tossed
• Claims Court Nixes Whistleblower's Bid For Denied IRS Award
• Pot Lobby Says Lowering Taxes Will Help Stem Vaping Crisis
• Real Estate Rumors: Amazon, G6 Hospitality, DL3 Realty
• Insurer Says Worker's Medical Pot Claim Barred By Fed. Law
• Opioid MDL Special Master Sets Data Production Guidelines
• A Privacy Law Question Facing Health Data Researchers
• Chubb Unit Needn't Cover Lab's $3.3M TCPA Deal
• Surefire Marketing Methods To Build Your Legal Practice
• Health Care Group Of The Year: Ropes & Gray
• Insys Exec Can't Delay 33-Month Prison Sentence, Gov't Says
• Top 10 Insurance Laws And Regulations Of The Decade
• Harvard Chem Chair Charged With Lying About China Ties
• DOJ Details Allscripts Unit's 'Abhorrent' Opioid Kickback Plot
• Insys Doc Who Lied About Ex-Colleagues Gets Nearly 5 Years
• Health Hires: Latham, Husch Blackwell, Verrill Dana
• 3rd-Party Funding Of FCA Cases Comes Under DOJ Scrutiny
• Allergan Divests To Get FTC Greenlight For $63B AbbVie Deal
• Nurse Staffing Co. Inks $3.2M Settlement To End OT Suit
• Pharmacies Can't Escape Public Nuisance In Opioid MDL
• UPMC Accused Of Giving Private Patient Info To Advertisers
• Drug Developer PPD Targets $1.53B For Public Debut
• Setting Boundaries: An Essential Skill For Lawyers
• Pharma Cos. Push 9th Circ. To Pause Calif. Pay-For-Delay Law
• 2nd Circ. Ruling Makes Messy Insider Trading Law Worse
• 'Pharma Bro' Accused Of Monopolizing Life-Saving Drug
• Health Care Group Of The Year: King & Spalding
• Partners Healthcare Must Face Trimmed ERISA Suit
• Fraud Claims In NY Breach Of Contract Cases Are Muddled
• High Court Lets Trump Admin Enforce 'Public Charge' Rule
• Why Noncompete Agreements Are Problematic In Health Care
• Expect More Pro-Business Rulings From NLRB This Year
• Ala. Hospital Beats Discovery Bid In Patient Suicide Suit
• 1st Circ. Asked To Restore Full $4.85M Early C-Section Award
• Insys Shows RICO As Good For Kapoor As For Whitey Bulger
• AmerisourceBergen Wants Del. Justices On Opioid Doc Fight
• Ill. High Court Upholds Workers' Comp Exemption
• Unions Find Organizing Cannabis Industry A Bumpy Road
• High Court Again Pauses Dental Dispute Ahead Of Trial
• FCA's Epic Run In 2010s Will Be Hard To Match In 2020s
• Calif. Wants Pot Shops To Post QR Codes Amid Vaping Crisis
• Bankruptcy Judge OKs $1.3M Bonus For Purdue CEO
• Gilead Says CDC Broke Promises After Taking Free HIV Drugs
• Clock Has Run Out For Hair-Loss Patients In Chemo MDL
• ABA Rules For Departing Attys Set Unprecedented Limits
• American HomePatient's $1M Deal Over Stolen Drives OK'd
• Texas Co. Sued Over Funds From $140M Hospital Delay Deal
• Eli Lilly Taps WellCare Health GC For Top Lawyer Spot
• Health Care Group Of The Year: Akin Gump
• Seven Firms To Steer 5 IPOs Exceeding $1.8B To End January
• Insurer Can't Slip Bad Faith Claims In Hospital Coverage Row
• NJ Hospital Can't Force Psych Test On Transgender Man
• 4 Takeaways From Roundup Jury Selection In St. Louis
• $1.8M Deal Wraps Up Parking Attendants' Health Plan Row
• Pa. Appeals Court Says Nurses' Wage Suit Dead On Arrival
• Cannabis Dispensaries, Customers Exposed In Data Breach
• Media Can Argue Truth Defense In Texas Defamation Case
• Pro-Employer NLRB Rulings May Prompt Handbook Reviews
• Insys Founder John Kapoor Gets 5½ Years
• State Dept. Introduces Visa Hurdles For Pregnant Women
• Insys VP Who Dressed As Dancing Opioid Gets 2 Years
• Ex-Md. Lawmaker Admits Guilt In Medical Pot Bribery Scheme
• US Trustee Targets Bonuses In Antibiotics Firm's Ch. 11
• ERISA Industry Group Slams New Seattle Hotel Benefits Law
• Bristol-Myers Wants $1.5B From Gilead After Cancer IP Trial
• Nissan Ex-CEO Illustrates Do's And Don'ts Of Image Repair
• What To Know Before Enforcing A Nicotine-Free Workplace
• HIPAA Compliance Lessons From 2019 Enforcement Trends
• DOT Cracks Downs On Emotional Support Animals On Flights
• Senators Unveil Bill Requiring Vape Cos. To Pay FDA
• Gov't Urges DC Circ. To Preserve Short-Term Insurance Rule
• Cooperating Insys CEO Gets 2½ Years In Prison
• Cerner Corp. Accused Of Mismanaging Retirement Plan
• Insys Exec Gets 1 Year As Atty Slams 'Salacious' Prosecution
• Ex-Insys Exec Blasts Big Pharma For Exploiting Women
• BCBS Wrongly Denied Mental Health Benefits, Magistrate Says
• Rite Aid Investors Challenging Walgreens Merger Win Cert.
• McKesson Beats Antitrust-Linked Derivative Suit, For Now
• Wilmington Trust Strikes $5M Deal To End ERISA Suit
• Dialysis Co. Says Revenue Gains Doom Investor Class Claims
• Health Care Firms Heat Up Jan. IPO Pipeline With 3 Offerings
• Mo. Medical Marijuana Co. Scores Early Win In Zoning Battle
• Estimating Antitrust Impact, Damages Via Natural Experiments
• Ill. Judge Rejects CVS' Bid To Block Class Cert. In TCPA Suit
• Delta Air Lines Sued For Dumping Jet Fuel On LA Playground
• Purdue, Creditors Ask To Keep Stay On Insurance Arbitration
• Stark Law Uncertainty Follows 3rd Circ.'s UPMC Opinion
• Moms Denied Class Cert. In ACA Lactation Coverage Suit
• Ex-NFLer Will Take Pot Decriminalization Bid To High Court
• ITC Decision Shows Importance Of Public Interest For Biotech
• Judge Questions Fees, Costs For Class Attys In Highmark Suit
• FDA Focus: What Ropes & Gray's Practice Chair Is Watching
• 3 Texas Hospital Systems Settle Nurses' Antitrust Claims
• Medical Device Co. Accused Of Upending $2B VA Contract
• Justices Won't Hear Appeal Of Psychiatrist Who Bribed IRS
• 2 Insys Execs Get Less Than 3 Years In Opioid Kickback Case
• Sheldon Silver Partly Slips Corruption Conviction At 2nd Circ.
• Debevoise Assists As Baring Notches $6.5B For 7th PE Fund
• Supreme Court Won't Speed Up ACA Petitions
• High Court ERISA Case Has States, Pharmacies On Edge
• Surescripts Can't Sink FTC's Monopoly Case
• Vape Injury Outbreak Mainly Tied To THC Products, CDC Says
• Hoffmann-La Roche Says Tamiflu FCA Suit 'Ignores Reality'
• DOJ Must Produce Docs On Separated Families' Mental Health
• 6th Circ. Is Told Opioid MDL Judge Flouting Court Rules
• Hollister Awarded $9.2M In Incontinence Device IP Row
• Pulling Up Stakes: Sidley, Baker Botts, Hogan Lovells
• Tanenbaum Keale Snags Marshall Dennehey Partner In Pa.
• Chancery Energizes Investor Bids To Probe Corporations
• Tech Giants Join Fight Against Trump 'Public Charge' Policy
• Justices Will Hear ACA Contraception Clash
• Honeywell Covers Retirees' Health Care To End Benefits Suit
• Obamacare Clings To Life As States Expand Medicaid
• Law360's Tort Report: Meat Loaf's Suit Out Of Hell
• Davis Polk, Covington Steer Clarivate's $950M DRG Buy
• BCBS Illegally Delayed Cancer Treatment Coverage, Suit Says
• Patient Can't Force Michigan To Tap New Pot Suppliers
• 11th Circ. Kills EMT's Harassment Suit Despite 'Unsavory' Acts
• Ex-Analysts Admit They Helped In Doctor's Office Ad Scheme
• DOJ Clears Optometry Org To Expand Purchasing Power
• Vape Group's Challenge To FDA's E-Cig Policy Falls Flat
• Feds Fight To Keep $122M Suit Against Texas Hospital
• 4th Circ. Secures Win For Nursing Home In Death Suit
• Gilead Hit With Another Antitrust Suit Over HIV Drugs
• HHS Drug Import Proposal Is Unlikely To Succeed
• Ex-Federal Prosecutor Joins Steptoe's LA White Collar Team
• Gov't To Pay $1M To End Suit Over Patient's Fatal Cancer
• 5 Key Issues Raised In Most CBD Product Class Actions
• 5th Circ. Says Staffing Co. Can Pursue Race Bias Suit
• Pharma Wholesaler Says Jury Should Decide $5.7M Fax Suit
• Wright Medical Hit With Suit To Halt $4B Sale To Stryker
• Tata Urges 7th Circ. To Toss $420M Trade Secrets Verdict
• How Associate Life Has Evolved Over The Past Decade
• Frazier Healthcare Amasses More Than $617M For Latest Fund
• Lipedema Patient Says Cigna's Liposuction Denials Unlawful
• Insys Wins OK For Ch. 11 Plan With Opioid Recovery Trust
• Liberty Aims To Preserve Win In Pharmacy's Painkiller Suit
• PTAB Weighs Sanofi Insulin Pen Patents In Mylan IP Row
• Audit Shows Minn. Regulators Can't Keep Up With Medical Pot
• 5th Circ.'s ACA Punt Gets Lambasted At Supreme Court
• ResMed Settles FCA Suits Over Referral Fraud For $39.5M
• New Data Shows 100B Opioid Pills Flooded U.S. Over 9 Years
• NY Court Says Doctor Must Face Childbirth Death Suit
• Contract Clash Ruling Leaves Fraught Dispute To Congress
• Del. Justices Weigh If Partnership Change Kills Standing
• Bayer Says 27K Essure Suits Can't Head 'Full-Steam' To Trial
• GSK Seeks To Forgo Trial In First Zofran MDL Bellwether
• LifeCare's Ch. 11 Liquidation Plan Gets Consensual OK
• A Wide Range Of Legal Priorities For Tribes In 2020
• Lawmakers Probe Easing Pot Research's Regulatory Gridlock
• 2nd Circ. Ruling Could Lower Bar For Insider Trading Charges
• Gov't Initiatives May Boost Health Coverage For Genetic Tests
• Robbins Approved To Lead Vape Co. Stock-Drop Suit
• 7th Circ. Lets Firms Take Share Of Bayer Settlement
• Trans Cop Says Bid To Ax Her Benefits Denial Suit 'Premature'
• Top 10 Employment Law Developments Of The Decade: Part 1
• Biotech Firm NantHealth's CEO Can't Escape Stockholder Suit
• Opioid Overdose Deaths On Decline, States Say
• UK Pharma Co. Scores Patent For Magic Mushroom Treatment
• Calif. Court Affirms $6M Arbitration Award For Brain Damage
• Feds Say 'Concise' Charges Against Ex-Theranos Exec Suffice
• Assisted Suicide Suit Heads To Mass. Appeals Court
• Viagra MDL Doomed As Plaintiffs' Experts Booted, Pfizer Says
• 2nd Circ. Won't Revive Aetna Nurse Consultant's OT Suit
• Justices Eyeing Dental Arbitration Dispute Ahead Of Trial
• VA Nurses Seek To Revive Locality Pay Adjustment Claims
• Lawmakers Told Lack Of Research Belies Pot's Risks, Benefits
• House Bill Would Let FDA Regulate CBD As A Supplement
• What Pa. Employment Suit Means For Medical Cannabis Users
• Gov't Contractor Suspension And Debarment: 2019 In Review
• 3rd Circ. Sheds Light On Ch. 11 Liability Release Approval
• Justices Asked To Permit DHS's 'Public Charge' Rule, For Now
• SmileDirect Claims Calif. Dental Board Continuing Harassment
• Medical Device Co. Hits Ch. 11 To Shed Most Of $104M Debt
• 2019 Trends In DOJ Civil Health Care Fraud Cases
• Health Tech Boom In 2020s Will Test Fraud, Privacy Laws
• NJ Appeals Court Shuts Down Injury Suit Over Bayer's Essure
• Cigna Says Texas Clinics Filed $2M In False Claims
• Breaking Down Brazil's 1st Data Protection Law
• Workers Sue Fla. For Failing To Cover Sex Reassignment
• FDA Says E-Cig Guidance Irrelevant To Vape Group's Suit
• Woman Slams Zimmer's Bid To Shake Off Hip Implant Suit
• Amid FDA Warnings, Hemp Companies Rethink CBD
• Fla. Pot Co. Says It Was Smeared In Short-Selling Scheme
• NY Court Tosses State's Ban On Flavored Vape Liquid
• IHS Hit With Suit Alleging Gov't Missed Fatal Cancer Diagnosis
• FDA Slams Theranos Execs' 'Unprecedented' Doc Bid
• Insurers Say Grocer Isn't Owed Defense Costs In Opioid Case
• Okla. AG Sues Opioid Distributors For Ignoring Red Flags
• Surescripts Says High Court Petitions Could Resolve FTC Row
• DC Circ. Seems Poised To Block Trump's Drug Pricing Rule
• Judging A Book: Dyk Reviews 'Democracy And Equality'
• Ex-Insys Exec Gets Nearly 3 Years For Opioid Kickbacks
• Cigna Workers Lose Bid For Redo On Benefits Ruling
• Insys Judge Wonders If Potential Punishment Is Too Harsh
• R1 RCM To Buy Health Care Tech Co. For $190M
• AmerisourceBergen Loses Bid To Shield Opioid Docs
• The Firms That Dominated In 2019
• Law360 Names Practice Groups Of The Year
• Vape Group Says FDA Admits Improper Regulation Of E-Cigs
• Calif. Pay-For-Delay Ban Won't Be Paused Pending Appeal
• GOP, Trump Assail ACA Fast Track At Supreme Court
• Conn. Nurse Injured During Procedure Can't Sue Patient
• Deal Makers Head To JP Morgan Conference In Bullish Mood
• Zimmer Wants Pa. Defective Hip Implant Case Tossed Again
• 8th Circ. Nixes Class Arbitration Bid In Benefit Manager Row
• 2019 Trends In DOJ Health Care Enforcement
• Reviewing 2019's White Collar Cases And Controversies
• High Court Wades Into ERISA Drug-Pricing Battle
• 'Polite F-U' Email Stays In States' Drug Price-Fixing Case
• Taxation With Representation: Ropes, Fried Frank, Weil
• Ky. Insurance Department Exits Suit Over Disability Benefits
• Okla. AG, Endo Reach $8.75M Deal Over Opioids
• How States Are Responding To The Insulin Price Crisis
• Judge Orders New Trial In Cook Medical Vein Filter Bellwether
• Pa. Lab Owner Guilty Of Paying Kickbacks For Medicare Tests
• What The Budget Bill Has In Store For Medical Cos.
• 7 Insider Tips For Working With In-House Counsel
• EU Clears $63B AbbVie-Allergan Deal With Drug Sale
• Weil, Fenwick Guide $1.1B Deal For Calif. Biopharma Co.
• Apple Hit With IP Suit Over Watch's Health Data Tracking Tech
• 9th Circ. Appears Split Over Pausing Immigration Rule Blocks
• Expert-Designation Issue Seals Woman's Med Mal Trial Loss
• BakerHostetler Adds KPMG Director To International Tax Team
• Law360's The Term: Abortion, Bridgegate And The ACA
• Chubb Says Insys Ch. 11 Plan Unclear On Insurance Terms
• Fed. Circ. Casts Doubt On Novartis MS Drug PTAB Win
• Commissioner Wants FTC Clampdown On Noncompetes
• Health Care Fraud Made Up Bulk Of Feds' $3B Recovery In '19
• Doc Urges 9th Circ. To Void $1M Patient Privacy Breach Award
• FDA To Hold Public Forum On Testing For Asbestos In Talc
• PE-Backed Contract Research Giant Files $100M IPO
• Young Sidley Vet Confirmed As Trump's 'Regulatory Czar'
• Medical Marijuana To Be On Mississippi Ballot
• 50 Years Later, Interpretive Challenges Remain For RICO
• Univ. Accused Of Hiding Counterfeit Surgery Tool Scheme
• Health Care AI Increasingly In Crosshairs Of State, Fed. Gov't
• The Top FMLA And ADA Decisions Of 2019: Part 1
• States Should Not Follow ABA On Attorney Conduct Rules
• 5th Circ. Decertifies 7,600-Person Class In Debt Collection Suit
• MD In Tricare Fraud Case Wants Conspiracy Charge Nixed
• Pfizer Beats False-Ad Suit Over FDA Approval Of Epinephrine
• Hospital Escapes Suit Over Unpaid $3.1M Med Mal Awards
• Pa. Doctor Keeps Trial Win In Suit Over Patient's Death
• Philly Injury Firm Inks Deal Over Medicare Reimbursements
• ACA Insurer Wants CVS To Reveal Discounted Drug Prices
• Lessons For Calif. Health Payors From 2019 Filing Trends
• 2nd Circ. Preserves Nationwide Block On Public Charge Rule
• 6th Circ. Upholds Doc's Conviction For Unnecessary Surgeries
• 9th Circ. Says Woman Who Stabbed Ex Can't Blame Lexapro
• 5th Circ. Won't Halt Dental Supply Case For High Court Review
• DOJ Corporate Plea Deals Face Increased Judicial Resistance
• How Courts And Litigants Can Benefit From Special Masters
• Concussion Testing Co. Wants False Ad Suit Tossed
• J&J's Talc Trial Deal Shows Power Of FDA's Asbestos Finding
• 10th Circ. Tosses Malpractice Suit Against Atty As Untimely
• Hospital, Whistleblower Told To Mediate Atty Fees In FCA Suit
• NJ Justices Doubt Workers' Comp Time Bar For Providers
• Medical Pot Co. Blasts Licensing Rules Before Fla. High Court
• Suit Over Adventist Health Church Exemption Nixed For Good
• 'Opioid Babies' Seek Class Cert. In MDL
• Dental Supply Co. Making Last Arbitration Push Ahead Of Trial
• Telemed Startup Says Fraud Accuser Can't Avoid Arbitration
• Digital Health Care Startup Raises €140M To Fund Expansion
• DOJ Backs 11th Circ. Challenge To Fla. Blue Cross Rules
• UnitedHealth Escapes Addiction Coverage Suit For Now
• Bankruptcy Courts Remain Inaccessible To Cannabis Cos.
• Uber Policy Calls For Refresher On ABA Confidentiality Rules
• AndroGel Antitrust Case Won't Get Moved To Georgia
• Allergan Accused Of Playing Dirty In Breast Implant MDL
• CVS, Walmart Look To Shift Blame To Doctors In Opioid MDL
• Vistria Wraps Up 3rd PE Fund With $1.11B In Tow
• Hospital Chain Reaches $53M Deal To End Stock Drop Suit
• USC's Landmark $215M Sex Abuse Deal Nears Final OK
• Insys Execs Say Restitution Should Be $18.4M, Not $306M
• Cigna Can't Use Privilege To Shield Info In NFL ERISA Suit
• New Mexico State Fair Settles Cannabis Free Speech Suit
• FTC Details 'New And Improved' Data Security Orders
• Rethinking Corporate Crisis And Litigation Communications
• Stericycle Escapes Funeral Homes' Suit Over Price Increases
• Judge Won't OK Class In 'Egregious' Hospital Sex Assault Suit
• Teva To Pay $54M To End FCA Suit Alleging Bribes To Doctors
• Johnson & Johnson Settles Calif. Talc Case Midtrial
• Medtronic Gets Patient's 'Defective' Pump Suit Trimmed
• 2 Health Care Cos. File IPOs Totaling $200M
• Gov't Asks 9th Circ. To Unblock Ban On Uninsured Immigrants
• 7th Circ. Won't Revisit $31M Kidney-Failure Ruling
• After Jury Deadlock, Doc Wants Kickback Charges Tossed
• Gov't. Says Justices Should Consider Overruling Hellerstedt
• Mental Health Clinic Inks $1.65M Deal To End FCA Suit
• Ga. Court Restores Med Mal Suit Over Patient's Dialysis Death
• 2 Overlooked Advantages Of Hourly Fees
• 2nd Circ. Deals Blow To Ex-NFLer's Pot Decriminalization Suit
• VA Told It Needs Better Way To Measure Health Facility Costs
• Pharma Tech Co. Sues Hemp Consultant Over IP 'Sabotage'
• 21 AGs, House Dems Urge Justices To Decide ACA's Fate
• The Top 10 Changes To Illinois Employment Law From 2019
• Washington State Latest To Target J&J Over Opioid Epidemic
• Wall Street Insider Trading Just Got Easier To Prosecute
• Blocking Calif. Dialysis Law Will Serve Public, Judge Says
• University Of Texas Hospital Beats Suit Over Patient's Death
• 200 GOP Lawmakers Ask High Court To Rethink Roe v. Wade
• 3rd Circ. Says It's No 'Amen Corner' For Arbitrator Rulings
• HUD Not Behind Cannabis Patient's Eviction, 9th Circ. Told
• 9th Circ. Won't Touch FCA Suit Over Off-Label Opioids
• Antibiotics Developer Plans Ch. 11 Sale To Escape $213M Debt
• Pharmacies Must Produce 14 Years Of Opioid Records In MDL
• NJ Docs Beat Suit Over NY Patient's Blindness
• FDA To Crack Down On Sale Of Some Flavored Vapes
• The Top 10 TCPA Cases Of 2019
• Ohio Sales Tax On Tampons Ruled Not Discriminatory
• Doc Can't Toss State Farm's $13M Insurance Claims RICO Suit
• Philly Hospital Owner Balks At Bid To Force Insurance Buy
• 401(k) Adviser Exits Banner Health ERISA Suit As Trial Looms
• California Pay-For-Delay Ban Headed To 9th Circ.
• 2020 May Be The Year Of The Great CBD Market Correction
• California Cases To Watch In 2020
• Health And Life Sciences Policy To Watch In 2020
• PE Attys Must Stay On Top Of These 6 Trends In 2020
• Florida Legislation To Watch In 2020
• Pa. Legislation And Regulation To Watch In 2020
• Opioid, Theranos Cases Among Key Trials To Watch In 2020
• 3 Cannabis Policy Trends To Watch In 2020
• Illinois Cases To Watch In 2020
• Personal Injury And Med Mal Cases To Watch In 2020
• Product Liability Legislation And Regulation To Watch
• Federal Tax Cases To Watch In 2020
• 5 Burning Questions Heading Into The 2020 IPO Market
• International Tax Cases To Watch In 2020
• Health Care Cases To Watch In 2020
• Texas Cases To Watch In 2020
• 5 Things To Watch In Litigation Finance This Year